BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21239864)

  • 1. Acute promyelocytic leukemia presenting with central nervous system involvement: a report of 2 cases.
    Ji M; Chi HS; Jang S; Park CJ; Lee JH; Seo JJ
    Korean J Lab Med; 2011 Jan; 31(1):9-12. PubMed ID: 21239864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute promyelocytic leukemia presenting with central nervous system involvement at initial diagnosis].
    Sakurai T; Kuroda H; Yamada M; Arihara Y; Jyomen W; Hirako T; Abe T; Fujii S; Maeda M; Fujita M; Kato J
    Rinsho Ketsueki; 2013 Jun; 54(6):574-8. PubMed ID: 23823097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
    Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
    Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
    Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
    Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.
    Gu BW; Hu J; Xu L; Yan H; Jin WR; Zhu YM; Zhao WL; Niu C; Cao Q; Su XY; Gu J; Ying HY; Chen Y; Xiong SM; Shen ZX; Chen Z; Chen SJ
    Hematol J; 2001; 2(5):330-40. PubMed ID: 11920269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.
    Diverio D; Rossi V; Avvisati G; De Santis S; Pistilli A; Pane F; Saglio G; Martinelli G; Petti MC; Santoro A; Pelicci PG; Mandelli F; Biondi A; Lo Coco F
    Blood; 1998 Aug; 92(3):784-9. PubMed ID: 9680345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia.
    Colovic N; Tomin D; Vidovic A; Tosic N; Atkinson HD; Colovic MD
    Med Oncol; 2012 Mar; 29(1):260-2. PubMed ID: 21298367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129.
    Slack JL; Willman CL; Andersen JW; Li YP; Viswanatha DS; Bloomfield CD; Tallman MS; Gallagher RE
    Blood; 2000 Jan; 95(2):398-403. PubMed ID: 10627441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
    Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
    Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.
    Wojiski S; Guibal FC; Kindler T; Lee BH; Jesneck JL; Fabian A; Tenen DG; Gilliland DG
    Leukemia; 2009 Aug; 23(8):1462-71. PubMed ID: 19322209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of PML/RARalpha gene rearrangement in suspected acute promyelocytic leukemia patients using dual-color fluorescence in situ hybridization on bone marrow smears].
    Zhu YL; Wu YF; Pan JL; Xue YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):757-60. PubMed ID: 15631655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia.
    Ohnishi K
    Int J Clin Oncol; 2007 Oct; 12(5):313-7. PubMed ID: 17929112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
    Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
    Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
    Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
    Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
    Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E
    Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance.
    Zayed A; Couban S; Hayne O; Sparavalo N; Shawwa A; Sadek I; Greer W
    Leuk Lymphoma; 2007 Mar; 48(3):489-96. PubMed ID: 17454588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.